News Focus
News Focus
icon url

jbog

03/02/11 9:54 PM

#115778 RE: DewDiligence #115772

I was surprised yesterday to see a report yesterday that Gilenia is taking very few Tysabri patients. Biogen has had a very nice run as of lately (+ $3 over the week).

Gilenia is still hurting Avonex and Copaxone.